TAVR Low Risk & CAS - Transcatheter Aortic Valve Replacement (TAVR) in Patients with the Medtronic Transcatheter Aortic Valve Replacement System (TAVR) in Patients at Low Risk for Surgical Aortic Valve Replacement (SAVR) Continued Access Trial

Disease Sites:

Not Available

Staging:

Phase IV

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Goel, Kashish

Participating Institutions:

Vanderbilt University

Open Date:

07-05-2016

Trial Type:

Other

Protocol ID:

CRE-INT0008

National Clinical Trial ID:

NCT02701283

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available